ATIP vs. BRTX, KDLY, MGRX, OTRK, ATPC, SSY, BGLC, ACON, VSEE, and DHAC
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), Agape ATP (ATPC), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Vsee Health (VSEE), and Digital Health Acquisition (DHAC). These companies are all part of the "healthcare" industry.
ATI Physical Therapy vs.
BioRestorative Therapies (NASDAQ:BRTX) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, community ranking, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.
ATI Physical Therapy has a net margin of -7.79% compared to BioRestorative Therapies' net margin of -2,697.08%. ATI Physical Therapy's return on equity of 0.00% beat BioRestorative Therapies' return on equity.
BioRestorative Therapies currently has a consensus price target of $18.00, indicating a potential upside of 928.57%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, equities research analysts clearly believe BioRestorative Therapies is more favorable than ATI Physical Therapy.
In the previous week, BioRestorative Therapies had 3 more articles in the media than ATI Physical Therapy. MarketBeat recorded 3 mentions for BioRestorative Therapies and 0 mentions for ATI Physical Therapy. BioRestorative Therapies' average media sentiment score of 0.80 beat ATI Physical Therapy's score of 0.00 indicating that BioRestorative Therapies is being referred to more favorably in the media.
69.4% of BioRestorative Therapies shares are held by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are held by institutional investors. 25.5% of BioRestorative Therapies shares are held by insiders. Comparatively, 3.3% of ATI Physical Therapy shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
ATI Physical Therapy received 13 more outperform votes than BioRestorative Therapies when rated by MarketBeat users. However, 100.00% of users gave BioRestorative Therapies an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote.
BioRestorative Therapies has a beta of 68.9, meaning that its share price is 6,790% more volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of -0.27, meaning that its share price is 127% less volatile than the S&P 500.
BioRestorative Therapies has higher earnings, but lower revenue than ATI Physical Therapy. BioRestorative Therapies is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.
Summary
BioRestorative Therapies beats ATI Physical Therapy on 11 of the 18 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ATI Physical Therapy Competitors List
Related Companies and Tools
This page (NYSE:ATIP) was last updated on 4/20/2025 by MarketBeat.com Staff
Buy ATIP Stock Free ATIP Stock Alerts